Press Release: NewLake Capital Partners Reports Third Quarter 2025 Financial Results

Dow Jones11-06

Third Quarter 2025 Revenue Totaled $12.6 Million, an Increase of 0.3% Year-Over-Year

Third Quarter 2025 Net Income Attributable to Common Stockholders Totaled $6.7 Million, Funds from Operations Totaled $10.7 Million, and Adjusted Funds from Operations Totaled $11.0 Million

Conference Call and Webcast Scheduled for November 6, 2025, at 11 a.m. Eastern Time

NEW CANAAN, Conn., Nov. 05, 2025 (GLOBE NEWSWIRE) -- NewLake Capital Partners, Inc. (OCTQX: NLCP) (the "Company" or "NewLake"), a leading provider of real estate capital to state-licensed cannabis operators, today announced its financial results for the third quarter ended September 30, 2025.

"During the third quarter we remained focused on proactive tenant management while maintaining the strength of our balance sheet," said Anthony Coniglio, NewLake's President and Chief Executive Officer. "Despite continued cannabis industry headwinds, NewLake is positioned to deliver lasting value for our shareholders."

Third Quarter 2025 Financial and Operational Highlights

   -- Revenue totaled $12.6 million. 
 
   -- Net income attributable to common stockholders totaled $6.7 million. 
 
   -- Funds From Operations ("FFO")(1) totaled $10.7 million. 
 
   -- Adjusted Funds From Operations ("AFFO")(1) totaled $11.0 million. 
 
   -- Declared a third quarter dividend of $0.43 per share of common stock, 
      equivalent to an annualized dividend $1.72 per common share. 

Comparison to the Third Quarter ended September 30, 2024

   -- Revenue remained flat at $12.6 million year-over-year. 
 
   -- Net income attributable to common stockholders totaled $6.7 million, as 
      compared to $6.4 million. 
 
   -- FFO totaled $10.7 million, as compared to $10.3 million, an increase of 
      3.8% year-over-year. 
 
   -- AFFO totaled $11.0 million, as compared to $10.8 million, an increase of 
      2.4% year-over-year. 
 
   -- For the third quarter ended September 30, 2025, the Company declared a 
      dividend of $0.43 per share of common stock, consistent to the third 
      quarter ended September 30, 2024. 

Nine Months Ended September 30, 2025 Financial and Operational Highlights

Comparison to the nine months ended September 30, 2024

   -- Revenue totaled $38.7 million, as compared to $37.6 million, an increase 
      of 3.0% year-over-year. 
 
   -- Net income attributable to common stockholders totaled $20.3 million, as 
      compared to $20.1 million. 
 
   -- FFO totaled $32.3 million, as compared to $31.4 million, an increase of 
      3.0% year-over-year. 
 
   -- AFFO totaled $33.2 million, as compared to $32.7 million, an increase of 
      1.4% year-over-year. 

Balance Sheet Highlights as of September 30, 2025

   -- Cash and cash equivalents as of September 30, 2025, were $23.6 million, 
      with approximately $1.1 million committed to fund future improvements. 
 
   -- Total liquidity of $106.0 million, consisting of cash and cash 
      equivalents and availability under the Company's Revolving Credit 
      Facility. 
 
   -- Gross real estate assets of $432.2 million. 
 
   -- 1.6% debt to total gross assets and a debt service coverage ratio of 
      approximately 85x. 
 
   -- No debt maturity until May 2027. 

((1) FFO and AFFO are presented on a dilutive basis.

Investment Activity

Acquisitions

The following table presents the Company's investment activity for the nine months ended September 30, 2025 (in thousands):

 
                                                         Real Estate 
                                              Closing    Acquisition 
   Tenant         Market        Site Type      Date         Costs 
------------   -------------   -----------   ---------   ------------ 
                                                Februa 
                                                 ry 19, 
 Cresco Labs         Ohio         Dispensary      2025    $        285 
                                                 April 
                                                  25, 
 Cresco Labs         Ohio         Dispensary      2025             500 
                                                 June 
                                                  12, 
 Curaleaf(1)     Pennsylvania     Dispensary      2025             950 
Total                                                    $      1,735 
                                                          =========== 
 

(1) This dispensary was acquired through a like-kind exchange and was recorded at its fair value. For further details, refer to the "Disposition" section below.

Disposition

On June 12, 2025, the Company completed a deed-for-deed like-kind exchange with a tenant, involving the transfer of its dispensary located in Mokena, IL for a dispensary located in Brookville, PA. The transaction was structured as a nonmonetary exchange with no cash consideration. Upon completion of the exchange, the Brookville property received by the Company was leased to a current tenant under a new operating lease. The Brookville dispensary was recorded at its estimated fair value of $950 thousand and the Company recognized a de minimis loss on the exchange. For additional details, refer to the acquisition summary in the table above.

Real Estate Commitments

Improvement Allowances

The following table presents the funded and remaining unfunded commitments as of September 30, 2025 (in thousands):

 
                                   Closing         Funded          Unfunded 
Tenant    Market     Site Type      Date        Commitments      Commitments 
 Cresco                               February 
  Labs       Ohio      Dispensary     19, 2025     $         --   $        705 
 Cresco 
  Labs       Ohio      Dispensary    April 25, 2025          --            375 
Total                                          $             --  $      1,080 
                                                  =============   =========== 
 
 

Condition of Our Tenants

Pottsville, PA and Sparks, NV Cultivation Facilities

On July 30, 2025, AYR Wellness Inc. ("AYR"), which operated at two of the Company's properties located in Pottsville, PA and Sparks, NV, announced that it had entered into a restructuring support agreement with its senior noteholders. Under the restructuring support agreement, certain AYR assets and operations will be acquired by the senior noteholders, while the remaining assets and operations, including those at the Company's leased properties, are to be sold or wound down.

The cultivation properties leased to AYR accounted for approximately 5.9% of the Company's rental income for the nine months ended September 30, 2025. AYR satisfied its rent obligations through July 2025; however, beginning in August 2025 through the end of the quarter, the Company did not receive rent for its Pottsville, PA and Sparks, NV cultivation properties, which AYR vacated during the quarter. The Company applied approximately $505.1 thousand of AYR's security deposits toward unpaid rent in the third quarter for the Pottsville and Sparks properties. At the end of the quarter, the combined remaining security deposits held by the Company totaled approximately $408.4 thousand across both properties. The Company intends to enforce all rights available under the applicable lease agreements.

Fitchburg, MA Cultivation Facility

Revolutionary Clinics, Inc. ("Revolutionary Clinics"), which leased the Company's Fitchburg, MA cultivation property, has experienced operational challenges that impaired its ability to meet contractual rent obligations. Beginning in June 2024, Revolutionary Clinics remitted approximately 50% of rent due. On December 13, 2024, the tenant entered into receivership. In the first quarter of 2025, the Company entered into a stipulation agreement with the court-appointed receiver to receive 50% of contractual rent on a weekly basis, along with weekly reimbursements for certain delinquent real estate taxes and utilities previously paid by the Company until the property was vacated and operations ceased. In July 2025, Revolutionary Clinics vacated the property, and rental payments ceased. The Company has engaged a broker and is actively marketing the property for lease and leasing efforts remain ongoing.

Financing Activity

Revolving Credit Facility

As of September 30, 2025, the Company had approximately $7.6 million in borrowings under the Revolving Credit Facility and $82.4 million in funds available to be drawn, subject to sufficient collateral in the borrowing base. The Revolving Credit Facility accrued interest at a fixed rate of 5.65% through May 5, 2025. Commencing May 6, 2025, the Revolving Credit Facility bears interest at a variable rate based upon the greater of (a) the Prime Rate quoted in the Wall Street Journal (Western Edition) plus an applicable margin of 1.0% or (b) 4.75%. As of September 30, 2025, the interest rate was at 8.25%.

The facility is subject to certain liquidity and operating covenants and includes customary representations and warranties, affirmative and negative covenants, and events of default. As of September 30, 2025, the Company was in compliance with the financial covenants under the agreement.

Dividend

On September 12, 2025, the Company's Board of Directors declared a third quarter 2025 cash dividend of $0.43 per share of common stock, equivalent to an annualized dividend of $1.72 per share of common stock. The dividend was paid on October 15, 2025, to stockholders of record at the close of business on September 30, 2025, and represents an AFFO payout ratio of 82%.

Recent Developments

On October 23, 2025, the Company amended its lease agreements with C3 Industries ("C3") to modify the terms of both the Hartford and Missouri leases. Under the amended Hartford lease, the Company agreed to pursue a sale of the Hartford property, and in connection with that agreement, C3 is required to reimburse the Company for any shortfall if the sale proceeds are less than the Company's investment basis. Conversely, if sale proceeds exceed the Company's basis, a portion of the excess will be paid to C3 as reimbursement for their investment in the property. C3 will continue to pay monthly base rent through the sale date. Upon completion of the sale, a portion of the rent previously allocated to the Hartford property will be reallocated to the Missouri lease, to compensate the Company for a portion of the income no longer received from the Hartford property. C3 will continue to pay this incremental rent under the Missouri lease until the Company invests in new properties with C3 pursuant to its right of first refusal agreement.

Conference Call and Webcast Details:

Management will host a conference call and webcast at 11:00 a.m. Eastern Time on November 6, 2025, to discuss its quarterly financial results and answer questions about the Company's operational and financial highlights for the third quarter ended September 30, 2025.

 
Event:      NewLake Capital Partners Inc. Third Quarter 2025 Earnings 
             Call 
Date:       Thursday, November 6, 2025 
Time:       11:00 a.m. Eastern Time 
Live Call:  1-877-407-3982 (U.S. Toll-Free) or 1-201-493-6780 
             (International) 
Webcast:    https://ir.newlake.com/news-events/ir-calendar 
            --------------------------------------------------------- 
 

For interested individuals unable to join the conference call, a dial-in replay of the call will be available until November 20, 2025, and can be accessed by dialing +1-844-512-2921 (U.S. Toll Free) or +1-412-317-6671 (International) and entering replay pin number: 13756168.

About NewLake Capital Partners, Inc.

NewLake Capital Partners, Inc. is an internally-managed real estate investment trust that provides real estate capital to state-licensed cannabis operators through sale-leaseback transactions and third-party purchases and funding for build-to-suit projects. NewLake owns a portfolio of 34 properties comprised of 15 cultivation facilities and 19 dispensaries that are leased to single tenants on a triple-net basis. For more information, please visit www.newlake.com.

Forward-Looking Statements

This press release contains "forward-looking statements." Forward-looking statements can be identified by words like "may," "will, " "likely," "should," "expect," "anticipate," "future," "plan," "believe, " "intend," "goal," "project," "continue" and similar expressions. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs and expectations. Forward-looking statements are based on the Company's current expectations and assumptions regarding capital market conditions, the Company's business, the economy and other future conditions. All of our statements regarding anticipated growth in our funds from operations, adjusted funds from operations, anticipated market conditions, and results of operations are forward-looking statements. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. For a discussion of the risks and uncertainties which could cause actual results to differ from those contained in the forward-looking statements, see "Risk Factors" in our most recent Annual Report on Form 10-K and any subsequent Quarterly Reports on Form 10-Q. The Company does not undertake, and specifically disclaims any obligation, to publicly release the result of any revisions which may be made to any forward-looking statements to reflect the occurrence of anticipated or unanticipated events or circumstances after the date of such statements, except as required by law.

Use of Non-GAAP Financial Information

FFO and AFFO are supplemental non-GAAP financial measures used in the real estate industry to measure and compare the operating performance of real estate companies. A complete reconciliation containing adjustments from GAAP net income attributable to common stockholders to FFO and AFFO and definitions of terms are included at the end of this release.

Contact Information:

Lisa Meyer

Chief Financial Officer, Treasurer and Secretary

NewLake Capital Partners, Inc.

lmeyer@newlake.com

Investor Contact:

Valter Pinto, Managing Director

KCSA Strategic Communications

NewLake@KCSA.com

PH: (212) 896-1254

Media Contact:

Ellen Mellody, Senior Vice President

KCSA Strategic Communications

EMellody@KCSA.com

PH: (570) 209-2947

 
                       NEWLAKE CAPITAL PARTNERS, INC. 
                         CONSOLIDATED BALANCE SHEETS 
                                 (Unaudited) 
             (In thousands, except share and per share amounts) 
 
                                 September 30, 2025      December 31, 2024 
                               ----------------------  --------------------- 
Assets: 
Real Estate 
    Land                        $          23,224       $          22,891 
    Building and Improvements             408,930                 408,552 
                                   --------------          -------------- 
Total Real Estate                         432,154                 431,443 
    Less Accumulated 
     Depreciation                         (54,698)                (44,709) 
                                   --------------          -------------- 
Net Real Estate                           377,456                 386,734 
Cash and Cash Equivalents                  23,569                  20,213 
In-Place Lease Intangible 
 Assets, net                               16,202                  17,794 
Loan Receivable, net (Current 
 Expected Credit Loss of $82 
 and $116, respectively)                    4,918                   4,884 
Other Assets                                1,852                   1,911 
                                   --------------          -------------- 
Total Assets                    $         423,997       $         431,536 
                                   ==============          ============== 
 
Liabilities and Equity: 
 
Liabilities: 
Accounts Payable and Accrued 
 Expenses                       $           1,303       $           1,515 
Revolving Credit Facility                   7,600                   7,600 
Dividends and Distributions 
 Payable                                    9,024                   9,246 
Security Deposits                           7,137                   8,117 
Rent Received in Advance                    1,271                     684 
Other Liabilities                              60                     402 
                                   --------------          -------------- 
Total Liabilities                          26,395                  27,564 
                                   --------------          -------------- 
 
Commitments and Contingencies 
 
Equity: 
   Preferred Stock, $0.01 Par 
   Value, 100,000,000 Shares 
   Authorized, 0 Shares 
   Issued and Outstanding, 
   respectively                                --                      -- 
   Common Stock, $0.01 Par 
    Value, 400,000,000 Shares 
    Authorized, 20,552,632 
    and 20,514,583 Shares 
    Issued and Outstanding, 
    respectively                              205                     205 
Additional Paid-In Capital                447,069                 446,627 
Accumulated Deficit                       (56,469)                (50,067) 
                                   --------------          -------------- 
Total Stockholders' Equity                390,805                 396,765 
 
Noncontrolling Interests                    6,797                   7,207 
                                   --------------          -------------- 
Total Equity                              397,602                 403,972 
                                   --------------          -------------- 
 
Total Liabilities and Equity    $         423,997       $         431,536 
                                   ==============          ============== 
 
 
                       NEWLAKE CAPITAL PARTNERS, INC. 
                    CONSOLIDATED STATEMENTS OF OPERATIONS 
                                 (Unaudited) 
              (In thousands, except share and per share amounts) 
 
                         Three Months Ended           Nine Months Ended 
                           September 30,                September 30, 
                     --------------------------  ---------------------------- 
                         2025          2024          2025          2024 
                                    ----------                  ---------- 
Revenue: 
Rental Income        $    12,335   $    12,276   $    37,485   $    36,657 
Interest Income 
 from Loans                  137           134           408           399 
Fees and 
 Reimbursables               115           144           835           562 
                      ----------    ----------    ----------    ---------- 
Total Revenue             12,587        12,554        38,728        37,618 
                      ----------    ----------    ----------    ---------- 
 
Expenses: 
Reimbursable 
 Property Expenses            46           128           713           179 
Property Carrying 
 Costs                       145            --           150            -- 
Depreciation and 
 Amortization 
 Expense                   3,874         3,726        11,634        10,920 
General and 
Administrative 
Expenses: 
    Compensation 
     Expense                 933         1,169         2,808         3,554 
    Professional 
     Fees                    334           475         1,137         1,120 
    Other General 
     and 
     Administrative 
     Expenses                350           433         1,314         1,307 
                      ----------    ----------    ----------    ---------- 
Total General and 
 Administrative 
 Expenses                  1,617         2,077         5,259         5,981 
                      ----------    ----------    ----------    ---------- 
Total Expenses             5,682         5,931        17,756        17,080 
                      ----------    ----------    ----------    ---------- 
 
Loss on Sale of 
 Real Estate                  --            --           (34)           -- 
Provision for 
 Current Expected 
 Credit Loss                  11            12            34            38 
                      ----------    ----------    ----------    ---------- 
 
Income From 
 Operations                6,916         6,635        20,972        20,576 
 
Other Income 
(Expense): 
Other Income                  97            80           274           262 
Interest Expense            (232)         (177)         (616)         (388) 
                      ----------    ----------    ----------    ---------- 
Total Other Income 
 (Expense)                  (135)          (97)         (342)         (126) 
 
Net Income                 6,781         6,538        20,630        20,450 
 
Net Income 
 Attributable to 
 Noncontrolling 
 Interests                  (115)         (116)         (348)         (363) 
                      ----------    ----------    ----------    ---------- 
 
   Net Income 
    Attributable to 
    Common 
    Stockholders     $     6,666   $     6,422   $    20,282   $    20,087 
                      ==========    ==========    ==========    ========== 
 
   Net Income 
    Attributable to 
    Common 
    Stockholders 
    Per Share - 
    Basic            $      0.32   $      0.31   $      0.98   $      0.98 
                      ==========    ==========    ==========    ========== 
 
   Net Income 
    Attributable to 
    Common 
    Stockholders 
    Per Share - 
    Diluted          $      0.32   $      0.31   $      0.98   $      0.98 
                      ==========    ==========    ==========    ========== 
 
   Weighted Average 
    Shares of 
    Common Stock 
    Outstanding - 
    Basic             20,629,562    20,578,838    20,613,788    20,558,754 
                      ==========    ==========    ==========    ========== 
 
   Weighted Average 
    Shares of 
    Common Stock 
    Outstanding - 
    Diluted           20,995,800    20,975,718    20,981,539    20,956,515 
                      ==========    ==========    ==========    ========== 
 

Non-GAAP Financial Information

Funds From Operations

The Company calculates FFO in accordance with the current National Association of Real Estate Investment Trusts ("NAREIT") definition. NAREIT currently defines FFO as follows: net income (loss) (computed in accordance with GAAP) excluding depreciation and amortization related to real estate, gains and losses from the sale of certain real estate assets, and impairment write-downs of certain real estate assets and investments in entities when the impairment is directly attributable to decreases in the value of depreciable real estate held by an entity. Other REITs may not define FFO in accordance with the NAREIT definition or may interpret the current NAREIT definition differently and therefore the Company's computation of FFO may not be comparable to such other REITs.

Adjusted Funds From Operations

The Company calculates AFFO by starting with FFO and adjusting for non-cash and certain non-recurring transactions, including non-cash components of compensation expense and the effect of provisions for credit loss. Other REITs may not define AFFO in the same manner and therefore the Company's calculation of AFFO may not be comparable to such other REITs. You should not consider FFO and AFFO to be alternatives to net income as a reliable measure of our operating performance; nor should you consider FFO and AFFO to be alternatives to cash flows from operating, investing or financing activities (as defined by GAAP) as measures of liquidity.

The table below is a reconciliation of net income attributable to common stockholders to FFO and AFFO for the three and nine months ended September 30, 2025 and 2024 (in thousands, except share and per share amounts):

 
                   Three Months Ended     Nine Months Ended 
                      September 30,         September 30, 
                  ---------------------  -------------------- 
                    2025      2024         2025      2024 
Net Income 
 Attributable to 
 Common 
 Stockholders     $ 6,666   $ 6,422      $20,282   $20,087 
Net Income 
 Attributable to 
 Noncontrolling 
 Interests            115       116          348       363 
                   ------    ------       ------    ------ 
Net Income          6,781     6,538       20,630    20,450 
 
Adjustments: 
Real Estate 
 Depreciation 
 and 
 Amortization       3,870     3,722       11,621    10,907 
Loss on Sale of 
Real Estate            --        --           34        -- 
                   ------    ------       ------    ------ 
FFO Attributable 
 to Common 
 Stockholders - 
 Diluted           10,651    10,260       32,285    31,357 
Provision for 
 Current 
 Expected Credit 
 Loss                 (11)      (12)         (34)      (38) 
Stock-Based 
 Compensation         316       449          750     1,223 
Non-cash 
 Interest 
 Expense               67        67          202       202 
Amortization of 
 Straight-line 
 Rent Expense          (1)       (1)          (4)       (2) 
                   ------    ------       ------    ------ 
AFFO 
 Attributable to 
 Common 
 Stockholders - 
 Diluted          $11,022   $10,763      $33,199   $32,742 
                   ======    ======       ======    ====== 
 
FFO per share -- 
 Diluted          $  0.51   $  0.49      $  1.54   $  1.50 
                   ======    ======       ======    ====== 
 
AFFO per share 
 -- Diluted       $  0.52   $  0.51      $  1.58   $  1.56 
                   ======    ======       ======    ====== 
 

(END) Dow Jones Newswires

November 05, 2025 18:44 ET (23:44 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment